clinical trial · NCT07538544
MCE Molecular Imaging for Myocarditis
Myocarditis AcuteMyocardial contrast echocardiography molecular imaging for inflammation
brief summary
Inflammation of the heart (myocarditis) is a serious condition that can cause heart failure, abnormal heart rhythms, cardiac arrest, and death. Rapid diagnosis of this condition is key to reversing it. The purpose of this study is to determine whether myocarditis such as that which occurs with viral illness, autoimmune conditions, or certain therapies (i.e. immune checkpoint inhibitors) can be diagnosed using a new form of ultrasound imaging of the heart (echocardiography) that uses a contrast agent that is targeted to inflammation (Sonazoid).
started
Sep 15, 2026
primary completion
Jun 30, 2030
completion
Jul 1, 2030
last updated
Aug 20, 2026
official title
MCE Molecular Imaging in Myocarditis
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol